In a major breakthrough for India’s pharmaceutical infrastructure, the upcoming Bulk Drug Park at Una in Himachal Pradesh has received environmental clearance from the Union Ministry of Environment, Forest and Climate Change (MoEF&CC). This milestone marks a decisive step toward establishing one of the country’s largest integrated facilities for the production of Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), aimed at reducing India’s dependency on imports and strengthening domestic manufacturing capabilities.
The project, being implemented by Himachal Pradesh Bulk Drug Park Infrastructure Ltd. (HPBDPIL)—a Special Purpose Vehicle under the state’s Industries Department—is expected to attract investments worth ₹8,000–₹10,000 crore and generate employment for over 15,000 people. With a total capital outlay of ₹2,071 crore, the initiative is backed by ₹996.45 crore in grant-in-aid from the Government of India and ₹1,074.55 crore from the Himachal Pradesh government.
Strategic Significance of the Una Bulk Drug Park
The Una Bulk Drug Park is part of the central government’s “Promotion of Bulk Drug Parks” scheme launched in March 2020, with guidelines notified by the Department of Pharmaceuticals in July 2020. The scheme aims to create world-class infrastructure for bulk drug manufacturing and reduce India’s reliance on imported raw materials, particularly from China.
| Project Component | Details |
|---|---|
| Location | Una, Himachal Pradesh |
| Total Capital Cost | ₹2,071 crore |
| Central Government Grant | ₹996.45 crore |
| State Government Contribution | ₹1,074.55 crore |
| Implementing Agency | HPBDPIL |
| Investment Potential | ₹8,000–₹10,000 crore |
| Employment Generation | 15,000–20,000 (direct & indirect) |
| Environmental Clearance Granted | September 2025 |
The park will house state-of-the-art facilities for API and KSM production, effluent treatment, warehousing, logistics, and quality control labs. It is expected to serve as a catalyst for pharmaceutical innovation and industrial growth in northern India.
Environmental Appraisal and Technical Validation
The environmental clearance was granted following rigorous appraisal by the Expert Appraisal Committee (EAC), which constituted a sub-committee for site inspection in January 2025. Technical assessments were conducted by NIT Hamirpur and validated by the Central Building Research Institute (CBRI), Roorkee. These assessments covered drainage patterns, ecological impact, seismic vulnerability, risk management, and landslide susceptibility.
| Environmental Assessment Criteria | Conducted By | Outcome |
|---|---|---|
| Drainage & Topography | NIT Hamirpur | Suitable |
| Ecological Disturbance | CBRI Roorkee | Minimal |
| Seismic Vulnerability | NIT + CBRI | Low to Moderate Risk |
| Risk & Disaster Management | CBRI Roorkee | Adequate Mitigation Measures |
| Landslide Susceptibility | NIT Hamirpur | Low |
The clearance ensures that the project complies with national environmental standards and is safe for long-term industrial operations.
Government and Industry Reactions
Chief Minister Sukhvinder Singh Sukhu hailed the clearance as a transformative moment for Himachal Pradesh, stating, “The Bulk Drug Park at Una will significantly strengthen our position as a leading hub of pharmaceutical manufacturing and generate large-scale employment opportunities for our youth.”
Industries Minister Harshwardhan Chauhan emphasized that the clearance would fast-track development and help achieve self-reliance in the pharma sector. Additional Chief Secretary R.D. Nazeem assured that the government is committed to ensuring timely completion of the project.
Industry leaders have also welcomed the move. B.R. Sikri, Chairman of the Federation of Pharma Entrepreneurs (FOPE), congratulated the government and noted that the park would create a robust and sustainable pharma ecosystem in the region.
Infrastructure and Development Timeline
The Bulk Drug Park will be developed in phases, with core infrastructure including roads, power supply, water systems, and effluent treatment facilities prioritized in the initial phase. The park will also feature a Common Facility Centre (CFC) to support small and medium enterprises (SMEs) in the pharma sector.
| Development Phase | Key Infrastructure Components | Timeline (Estimated) |
|---|---|---|
| Phase I | Roads, Power, Water, ETP, CFC | Q2 2026 |
| Phase II | Warehousing, R&D Labs, Logistics Hub | Q4 2026 |
| Phase III | Full Operationalization & Expansion | Q2 2027 |
The Industries Department has committed to executing the project in a time-bound manner, with regular monitoring and stakeholder engagement.
Economic and Employment Impact
The Bulk Drug Park is expected to be a game-changer for Himachal Pradesh’s economy. Apart from direct employment in manufacturing and operations, the park will create indirect opportunities in construction, logistics, hospitality, and ancillary services.
| Employment Category | Estimated Jobs Created |
|---|---|
| Direct Manufacturing | 8,000–10,000 |
| Indirect Services | 7,000–10,000 |
| Skill Development | 2,000+ (Training Programs) |
The state government plans to launch skill development initiatives in collaboration with pharma companies and academic institutions to prepare the local workforce for high-value jobs.
National Context and Strategic Goals
India currently imports over 60% of its API and KSM requirements, primarily from China. The Una Bulk Drug Park is part of a national strategy to reverse this trend and build domestic capacity. Alongside similar parks in Andhra Pradesh and Gujarat, the Una facility will play a pivotal role in achieving pharmaceutical self-sufficiency.
| API/KSM Dependency | Current Status | Target by 2030 |
|---|---|---|
| Import Dependency | ~60% | <20% |
| Domestic Production | ~40% | >80% |
| Export Potential | Moderate | High |
The park will also support India’s ambition to become a global supplier of affordable and high-quality medicines, especially in the post-COVID era where supply chain resilience is critical.
Conclusion: A Milestone for Himachal’s Industrial Future
The environmental clearance for the Bulk Drug Park at Una marks a significant milestone in India’s journey toward pharmaceutical self-reliance. With robust infrastructure, strategic location, and strong policy support, the park is poised to become a cornerstone of India’s pharma manufacturing landscape.
As construction begins, the project promises to deliver economic growth, employment, and innovation, not just for Himachal Pradesh but for the entire country. The successful execution of this initiative will set a benchmark for future industrial parks and reinforce India’s position as a global pharma powerhouse.
Disclaimer: This article is based on publicly available government statements, technical reports, and industry inputs. It is intended for informational purposes only and does not constitute investment or legal advice. All figures and timelines are subject to change based on regulatory approvals and project execution.
